pyrimidin-2-one beta-ribofuranoside and Cancer of Head

pyrimidin-2-one beta-ribofuranoside has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fares, F; Napso, T	1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Cancer of Head

Article	Year
Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells. International journal of oncology, 2014, Volume: 44, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Cyclin-Dependent Kinase Inhibitor p21; Cytidine; Delayed-Action Preparations; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Promoter Regions, Genetic; Protein Kinases; Signal Transduction	2014

Article

Year

Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells.

International journal of oncology, 2014, Volume: 44, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Cyclin-Dependent Kinase Inhibitor p21; Cytidine; Delayed-Action Preparations; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Promoter Regions, Genetic; Protein Kinases; Signal Transduction

2014